litlas
Log inCreate account

Mary Sano

Active 1978–2026

160
Papers
30,978
Citations
86
h-index
157
i10-index

Citations

Citations per year for Mary Sano1978: 2 citations1979: 8 citations1980: 7 citations1981: 17 citations1982: 20 citations1983: 10 citations1984: 5 citations1985: 3 citations1986: 11 citations1987: 6 citations1988: 12 citations1989: 13 citations1990: 13 citations1991: 19 citations1992: 19 citations1993: 30 citations1994: 23 citations1995: 26 citations1996: 45 citations1997: 72 citations1998: 129 citations1999: 129 citations2000: 219 citations2001: 275 citations2002: 260 citations2003: 259 citations2004: 303 citations2005: 287 citations2006: 347 citations2007: 291 citations2008: 337 citations2009: 277 citations2010: 334 citations2011: 301 citations2012: 286 citations2013: 288 citations2014: 262 citations2015: 257 citations2016: 256 citations2017: 253 citations2018: 250 citations2019: 783 citations2020: 812 citations2021: 807 citations2022: 685 citations2023: 538 citations2024: 809 citations2025: 447 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,243 citing papers, 32.3% of this breakdownUnited Kingdom: 1,080 citing papers, 8.2% of this breakdownChina: 780 citing papers, 6% of this breakdownCanada: 681 citing papers, 5.2% of this breakdownItaly: 558 citing papers, 4.3% of this breakdownGermany: 525 citing papers, 4% of this breakdownAustralia: 438 citing papers, 3.3% of this breakdownNetherlands: 386 citing papers, 2.9% of this breakdownFrance: 377 citing papers, 2.9% of this breakdownSpain: 345 citing papers, 2.6% of this breakdownSweden: 286 citing papers, 2.2% of this breakdownJapan: 261 citing papers, 2% of this breakdown
0%32.3%Other 24.1%

Institutions

Fields

  • Medicine68.6%
  • Neuroscience10.9%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Psychology2.1%
  • Health Professions1.8%
  • Computer Science1.3%
  • Other4.8%

Topics

  • Alzheimer's disease research and treatments11.3%
  • Dementia and Cognitive Impairment Research10.6%
  • Cholinesterase and Neurodegenerative Diseases3.1%
  • Neuroinflammation and Neurodegeneration Mechanisms2.4%
  • Parkinson's Disease Mechanisms and Treatments1.9%
  • Tryptophan and brain disorders1.9%
  • Other68.8%

Coauthors

All papers

Open in search
  1. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

    Authors: Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft, Christopher H. van Dyck, Jacobo Mintzer, Brigid Reynolds, James B. Brewer, Robert A. Rissman, Rema Raman, Paul Aisen, For the Alzheimer's Disease Cooperative Study, Alzheimer's Disease Cooperative Study, Jacobo Mintzer, Brent A. Reynolds, Jason Karlawish, Douglas Galasko, Judith L. Heidebrink, Neel Aggarwal, Neill R. Graff‐Radford, Mary Sano, Ronald C. Petersen, Katheryn A. Bell, Rachelle S. Doody, Alisha J Smith, Charles Bernick, A. Porteinsson, Pierre N. Tariot, Ruth A. Mulnard, A. Lerner, Luisa‐Sophie Schneider, Jane C. Burns, Murray A. Raskind, Steven H. Ferris, Gregory A. Jicha, M. Quiceno, Thomas O. Obisesan, Paul B. Rosenberg, Daniel Weintraub, Karl Kieburtz, Bruce L. Miller, Richard J. Kryscio, G. Alexopoulis - Neurology 2015 cited by 699

  2. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus

    Authors: Ben Readhead, Jean‐Vianney Haure‐Mirande, Cory C. Funk, Matthew A. Richards, Paul Shannon, Vahram Haroutunian, Mary Sano, Winnie S. Liang, Noam D. Beckmann, Nathan D. Price, Eric M. Reiman, Eric E. Schadt, Michelle E. Ehrlich, Sam Gandy, Joel T. Dudley - Neuron 2018 cited by 729

  3. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

    Authors: Vivianna M. Van Deerlin, Patrick Sleiman, Maria Martinez‐Lage, Alice Chen‐Plotkin, Li-San Wang, Neill R. Graff‐Radford, Dennis W. Dickson, Rosa Rademakers, Bradley F. Boeve, Murray Grossman, Steven E. Arnold, David Mann, Stuart Pickering‐Brown, Harro Seelaar, Peter Heutink, John C. van Swieten, Jill R. Murrell, Bernardino Ghetti, Salvatore Spina, Jordan Grafman, John R. Hodges, Maria Grazia Spillantini, Sid Gilman, Andrew P. Lieberman, Jeffrey Kaye, Randall L. Woltjer, Eileen H. Bigio, Marsel Mesulam, Safa Al‐Sarraj, Claire Troakes, Roger N. Rosenberg, Charles L. White, Isidró Ferrer, Albert Lladó, Manuela Neumann, Hans A. Kretzschmar, Christine M. Hulette, Kathleen A. Welsh‐Bohmer, Bruce L. Miller, Ainhoa Alzualde, Adolfo López de Munain, Ann C. McKee, Marla Gearing, Allan I. Levey, James J. Lah, John Hardy, Jonathan D. Rohrer, Tammaryn Lashley, Ian R. Mackenzie, Howard Feldman, Ronald L. Hamilton, Steven T. DeKosky, Julie van der Zee, Samir Kumar‐Singh, Christine Van Broeckhoven, Richard Mayeux, Jean Paul Vonsattel, Juan C. Troncoso, Jillian J. Kril, John B. Kwok, Glenda M. Halliday, Thomas D. Bird, Paul G. Ince, Pamela J. Shaw, Nigel J. Cairns, John C. Morris, Catriona McLean, Charles DeCarli, William G. Ellis, Stefanie H. Freeman, Matthew P. Frosch, John H. Growdon, Daniel P. Perl, Mary Sano, David A. Bennett, Julie A. Schneider, Thomas G. Beach, Eric M. Reiman, Bryan K. Woodruff, Jeffrey L. Cummings, Harry V. Vinters, Carol A. Miller, Helena C. Chui, Irina Alafuzoff, Päivi Hartikainen, Danielle Seilhean, Douglas Galasko, Eliezer Masliah, Carl W. Cotman, MJ Tuñón, Mònica Martínez, David G. Muñoz, Steven L. Carroll, Daniel Marson, Peter Riederer, Nenad Bogdanović, Gerard D Schellenberg, Håkon Håkonarson, John Q. Trojanowski, Virginia M.‐Y. Lee - Nature Genetics 2010 cited by 609

  4. Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs

    Authors: Richard C. Mohs, David S. Knopman, Ronald C. Petersen, Steven H. Ferris, Chris Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Chris M. Clark, Leon J. Thal - Alzheimer Disease & Associated Disorders 1997 cited by 703

  5. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimerʼs Disease

    Authors: Douglas Galasko, David A. Bennett, Mary Sano, Chris Ernesto, Ronald J. Thomas, Michael Grundman, Steven H. Ferris - Alzheimer Disease & Associated Disorders 1997 cited by 1,193

  6. Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease

    Authors: Maurice W. Dysken, Mary Sano, Sanjay Asthana, Julia E. Vertrees, Muralidhar Pallaki, Maria D. Llorente, Susan Love, Gerard D. Schellenberg, J. Riley McCarten, Julie Malphurs, Susana Prieto, Peijun Chen, David Loreck, George A. Trapp, Rajbir Bakshi, Jacobo Mintzer, Judith L. Heidebrink, Ana Vidal‐Cardona, Lillian M. Arroyo, Angel R. Cruz, Sally B. Zachariah, Neil W. Kowall, Mohit P. Chopra, Suzanne Craft, Stephen Thielke, Carolyn Turvey, Catherine Woodman, Kimberly A. Monnell, Kimberly Gordon, Julie Tomaska, Yoav Segal, Peter Peduzzi, Peter Guarino - JAMA 2013 cited by 615

  7. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

    Authors: Ronald Petersen, Ronald G. Thomas, Michael Grundman, David Bennett, Rachelle S. Doody, Steven H. Ferris, Douglas Galasko, Shelia Jin, Jeffrey Kaye, Allan I. Levey, Eric Pfeiffer, Mary Sano, Christopher H. van Dyck, Leon J. Thal - New England Journal of Medicine 2005 cited by 1,858

  8. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

    Authors: Doug Galasko, David Bennett, Mary Sano, Christopher Ernesto, Ronald J. Thomas, M Grundman, Steven H. Ferris - 1997 cited by 775

  9. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

    Authors: Richard C. Mohs, David S. Knopman, R. Petersen, Steven H. Ferris, Christopher Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Camilla N. Clark, L. J. Thal - 1997 cited by 493

  10. A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

    Authors: Mary Sano, Christopher Ernesto, Ronald G. Thomas, Melville R. Klauber, Kimberly Schafer, Michael Grundman, Peter Woodbury, John H. Growdon, Carl W. Cotman, Eric Pfeiffer, Lon S. Schneider, Leon J. Thal - New England Journal of Medicine 1997 cited by 2,383

  11. Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery

    Authors: Stacie Deiner, Xiaodong Luo, Hung‐Mo Lin, Daniel I. Sessler, Leif Saager, Frederick E. Sieber, Hochang B. Lee, Mary Sano, and the Dexlirium Writing Group, Christopher J. Jankowski, Sergio D. Bergese, Keith Candiotti, Joseph H. Flaherty, Harendra Arora, Aryeh Shander, Peter Rock - JAMA Surgery 2017 cited by 342

  12. evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease

    Authors: Jeffrey L. Cummings, Alireza Atri, Howard Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens - Alzheimer s Research & Therapy 2025 cited by 123

  13. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer’s disease

    Authors: Dawn Matthews, Xiangling Mao, Kathleen Dowd, Diamanto Tsakanikas, Caroline S. Jiang, Caroline Meuser, Randolph D. Andrews, Ana Lukić, Jihyun Lee, Nicholas Henry Hampilos, Neeva Shafiian, Mary Sano, P. David Mozley, Howard Fillit, Bruce S. McEwen, Dikoma C. Shungu, Ana C. Pereira - Brain 2021 cited by 95

  14. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition

    Authors: Jeffrey L. Cummings, Jacobo Mintzer, Henry Brodaty, Mary Sano, Sube Banerjee, D. P. Devanand, Serge Gauthier, Robert Howard, Krista L. Lanctôt, Constantine G. Lyketsos, Elaine R. Peskind, Anton P. Porsteinsson, Edgardo Reich, Cristina Sampaio, David C. Steffens, Marc Wortmann, Kate Zhong - International Psychogeriatrics 2014 cited by 353

  15. Diagnostic criteria for apathy in neurocognitive disorders

    Authors: David S. Miller, Philippe Robert, Larry Ereshefsky, Lawrence Adler, Daniel R. Bateman, Jeff Cummings, Steven T. DeKosky, Corinne E. Fischer, Masud Husain, Zahinoor Ismail, Judith Jaeger, Alan J. Lerner, Abby Li, Constantine G. Lyketsos, Valéria Manera, Jacobo Mintzer, Hans J. Moebius, Moyra E. Mortby, Didier Meulien, Stephane Pollentier, Anton P. Porsteinsson, J. Rasmussen, Paul B. Rosenberg, Myuri Ruthirakuhan, Mary Sano, Carla Zucchero Sarracini, Krista L. Lanctôt - Alzheimer s & Dementia 2021 cited by 174

  16. A randomized, double‐blind, placebo‐controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot study

    Authors: Carolyn W. Zhu, Hillel Grossman, Judith Neugroschl, Susan Parker, Amanda R. Burden, Xiaodong Luo, Mary Sano - Alzheimer s & Dementia Translational Research & Clinical Interventions 2018 cited by 120

  17. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

    Authors: Mary Sano, Karen L. Bell, Douglas Galasko, James E. Galvin, Ronald G. Thomas, C H van Dyck, Paul Aisen - Neurology 2011 cited by 329

  18. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition

    Authors: Jeffrey L. Cummings, Luiz Cortez Pinto, Manuel Padilla de la Cruz, Corinne E. Fischer, Debby L. Gerritsen, George T. Grossberg, Tzung‐Jeng Hwang, Zahinoor Ismail, Dilip V. Jeste, Raymond T.C.M. Koopmans, Krista L. Lanctôt, Raimundo Mateos, Susan Peschin, Cristina Sampaio, Debby W. Tsuang, Huali Wang, Kate Zhong, Lisa J. Bain, Mary Sano - American Journal of Geriatric Psychiatry 2020 cited by 88

  19. Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definition

    Authors: Mary Sano, Jeffrey L. Cummings, Stefanie Auer, Sverre Bergh, Corinne E. Fischer, Debby L. Gerritsen, George T. Grossberg, Zahinoor Ismail, Krista L. Lanctôt, Maria I. Lapid, Jacobo Mintzer, Rebecca Palm, Paul B. Rosenberg, Michael Splaine, Kate Zhong, Carolyn W. Zhu - International Psychogeriatrics 2023 cited by 80

  20. evoke and evoke+: design of two large‐scale, double‐blind, placebo‐controlled, phase 3 studies evaluating the neuroprotective effects of semaglutide in early Alzheimer’s disease

    Authors: Alireza Atri, Howard Feldman, Charlotte T. Hansen, Julie Broe Honoré, Peter Johannsen, Filip K. Knop, Pernille Poulsen, Lars Lau Rakêt, Mary Sano, Hilkka Soininen, Jeffrey L. Cummings - Alzheimer s & Dementia 2022 cited by 23

  21. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

    Authors: Paul Aisen, Kimberly Schafer, Michael Grundman, Eric Pfeiffer, Mary Sano, Kenneth L. Davis, Martin R. Farlow, Shelia Jin, Ronald G. Thomas, Leon J. Thal - 2003 cited by 968

  22. Clinical Dementia Rating training and reliability in multicenter studies

    Authors: John C. Morris, Christopher Ernesto, Kimberly Schafer, M. Coats, Susan A. Leon, Mary Sano, L. J. Thal, Peter Woodbury - Neurology 1997 cited by 382

  23. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy

    Authors: Jamie M. Walker, Timothy E. Richardson, Kurt Farrell, Megan A. Iida, Chan Foong, Ping Shang, Johannes Attems, Gai Ayalon, Thomas G. Beach, Eileen H. Bigio, Andrew E. Budson, Nigel J. Cairns, María M. Corrada, Etty Cortés, Dennis W. Dickson, Peter Fischer, Margaret E. Flanagan, Erin Franklin, Marla Gearing, Jonathan D. Glass, Lawrence A. Hansen, Vahram Haroutunian, Patrick R. Hof, Lawrence S. Honig, Claudia H. Kawas, C. Dirk Keene, Julia Kofler, Gábor G. Kovács, Edward B. Lee, Mirjam I. Lutz, Qinwen Mao, Eliezer Masliah, Ann C. McKee, Corey T. McMillan, M.‐Marsel Mesulam, Melissa E. Murray, Peter T. Nelson, Richard J. Perrin, Thao Pham, Wayne W. Poon, Dushyant P. Purohit, Robert A. Rissman, Kenji Sakai, Mary Sano, Julie A. Schneider, Thor D. Stein, Andrew F. Teich, John Q. Trojanowski, Juan C. Troncoso, Jean-Paul G. Vonsattel, Sandra Weıntraub, David A. Wolk, Randall L. Woltjer, Masahito Yamada, Lei Yu, Charles L. White, John F. Crary - Journal of Neuropathology & Experimental Neurology 2020 cited by 71

  24. The Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for specialty care

    Authors: Bradford C. Dickerson, Alireza Atri, Carolyn Clevenger, Jason Karlawish, David S. Knopman, Pei‐Jung Lin, Mary S. Norman, Chiadi U. Onyike, Mary Sano, Susan Scanland, María C. Carrillo - Alzheimer s & Dementia 2024 cited by 38